CapitalBio Technology Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 2,000

Employees

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 6

CapitalBio Technology General Information

Description

Developer of biochip, medical equipment and detection technology designed for medical research. The company has developed a biochip technology platform, established a new generation of biological detection technology system covering chips, sequencing, multiplex PCR, mass spectrometry and cell sorting as the core, providing equipment, reagents and consumables, software and other services for life science research institution, clinical medicine institution and new drug research and development institution.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Building C, Yizhuang Biomedical Park
  • No. 88 Kechuang Sixth Street, Technology Development Zone
  • Beijing, 101111
  • China
+86 010
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Laboratory Services (Healthcare)
Medical Supplies
Vertical(s)
Corporate Office
  • Building C, Yizhuang Biomedical Park
  • No. 88 Kechuang Sixth Street, Technology Development Zone
  • Beijing, 101111
  • China
+86 010

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CapitalBio Technology Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore CapitalBio Technology‘s full profile, request access.

Request a free trial

CapitalBio Technology Patents

CapitalBio Technology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021100526-A4 Complete set of snp primer for intervention effect evaluation of metabolic abnormalities and application thereof Inactive 27-Jan-2021
US-20160231223-A1 Fluidic chip for flow cytometry and methods of use Inactive 10-Feb-2015
US-20160092719-A1 Method for monitoring, identification, and/or detection using a camera based on a color feature Active 26-Sep-2014
US-9818204-B2 Method for monitoring, identification, and/or detection using a camera based on a color feature Active 26-Sep-2014
EP-3113886-A1 A multi-index detection microfluidic chip and methods of use Active 07-Mar-2014 B01L3/5027
To view CapitalBio Technology’s complete patent history, request access »

CapitalBio Technology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CapitalBio Technology Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore CapitalBio Technology‘s full profile, request access.

Request a free trial

CapitalBio Technology FAQs

  • When was CapitalBio Technology founded?

    CapitalBio Technology was founded in 2012.

  • Where is CapitalBio Technology headquartered?

    CapitalBio Technology is headquartered in Beijing, China.

  • What is the size of CapitalBio Technology?

    CapitalBio Technology has 2,000 total employees.

  • What industry is CapitalBio Technology in?

    CapitalBio Technology’s primary industry is Diagnostic Equipment.

  • Is CapitalBio Technology a private or public company?

    CapitalBio Technology is a Private company.

  • What is CapitalBio Technology’s current revenue?

    The current revenue for CapitalBio Technology is .

  • How much funding has CapitalBio Technology raised over time?

    CapitalBio Technology has raised $128M.

  • Who are CapitalBio Technology’s investors?

    Sichuan Energy Investment Development, H-young Investment, Winshare Capital, Country Garden Venture Capital, and Friend Capital are 5 of 19 investors who have invested in CapitalBio Technology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process